Once again, the EMB Group participated in the 34th ESHRE 2018 annual meeting, which took place in Barcelona, from 1st to 4th July 2018 in the “Centro de Convenciones Internacional de Barcelona (CCIB)”.

During this meeting was held the Vitrolife Scientific Symposium "How to optimise the efficiency and outcomes of your IVF procedures." Where three experienced speakers, Dr. Andrew Kan, Prof. David Gardner and Dr. Mandy Katz-Jaffe shared their experience regarding this topic with all the assistants.

For further information:

http://info.vitrolife.com/vitrolife-scientific-symposium-at-eshre-2018?utm_campaign=2018_Newsletters&utm_source=hs_email&utm_medium=email&utm_content=63998186&_hsenc=p2ANqtz-80m7nu0LRzexO9IBFp8JGIzc6lEBX1L5bkm5wqmGuNCq72jmq-FqVOR3gGW36M1orodxCZ_OATuwHVEb2w3-BNGhOIBg&_hsmi=64016587

 

Grupo EMB has participated in the XI Congress of Gynecological Endoscopy of the Endoscopy Section of SEGO. The meeting took place on June 14-15, 2018 at the Mar de Vigo Conference Center (Pontevedra).

This Congress has aimed to hold a conference of great scientific interest where live surgery, current reports in the field and discussion forums has been integrated together.

Grupo EMB attended all the professionals visiting us at booth number 12 of the premises, where the PlasmaJet® precision surgical dissector has been presented.

 

 

Grupo EMB was present in the 32nd National Congress of the Spanish Fertility Society (SEF) which took place on May 16-18, 2018 in the Municipal Conference Center located in the Campo de las Naciones in Madrid.

In this new edition of the National Congress of the SEF, the reproduction centers of the city of Madrid participated with the support of the most significant local and regional institutions.

The Congress promoted the participation of all the attendees, paying special attention to the diffusion of the scientific activity. Grupo EMB was pleased to host all the participants visiting us (stand 24 of the meeting center).

Hospital Dexeus in Barcelona has applied for the first time in Spain to apply a new and less aggressive technology for endometriosis surgery that provides a better preservation of the patients’ ovarian function.

Dr. Pere Barri, coordinator of the Surgical Section and responsible for the Endometriosis Unit of Dexeus Mujer and the Obstetrics, Gynecology and Reproduction Department of the Hospital Dexeus, explained that the new technique is based on the use of an inert gas that destroys pathological tissues vaporizing them, without damaging the adjacent structures.

According to Dr. Barri, “the surgery of this type of endometriosis is one of the major surgical challenges of gynecology, since organs of the digestive, urinary or even nervous system are often affected, and when it affects the ovaries it can reduce its reproductive function”.

The new technology allows to be more respectful with the healthy ovary as said by Dr. Barri, "which is key in these cases, given that most of those affected are women under 40 years of age".

In fact, between 30% and 50% of women with endometriosis experience fertility problems, a figure that increases with the delay of the age of motherhood.

In addition, it is estimated that currently in Spain there are one million women affected by this pathology and more than 200 million worldwide.

The new PlasmaJet technology, developed by Plasma Surgical, Inc., is a system exclusively distributed by Grupo EMB in Spain and Portugal and, as stated by Dr. Barri, “it has shown to be safer and more versatile than lasers and other electrosurgical technologies, in addition to be able to guarantee a lower recurrence rate".

For further information please refer to: http://www.elmundo.es/cataluna/2018/03/12/5aa699fbe2704ed73f8b470b.html